Human papillomavirus negative cervical cancers and precancerous lesions: prevalence, pathological and molecular features, and clinical implications

Background: Cervical cancer is the fourth most common cancer in women globally. Although human papillomavirus (HPV) testing plays an increasing role in cervical cancer screening and treatment, HPV-negative cervical cancer remains a consistently reported entity globally. While numerous studies have f...

Full description

Saved in:
Bibliographic Details
Main Authors: Liron Pantanowitz, Chengquan Zhao, Xianxu Zeng, Wenli Dai
Format: Article
Language:English
Published: BMJ Publishing Group 2025-02-01
Series:Gynecology and Obstetrics Clinical Medicine
Online Access:https://gocm.bmj.com/content/5/1/e000160.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850272763711848448
author Liron Pantanowitz
Chengquan Zhao
Xianxu Zeng
Wenli Dai
author_facet Liron Pantanowitz
Chengquan Zhao
Xianxu Zeng
Wenli Dai
author_sort Liron Pantanowitz
collection DOAJ
description Background: Cervical cancer is the fourth most common cancer in women globally. Although human papillomavirus (HPV) testing plays an increasing role in cervical cancer screening and treatment, HPV-negative cervical cancer remains a consistently reported entity globally. While numerous studies have focused on HPV-positive cervical cancers, detailed studies on HPV-negative counterparts remain limited.Results: This literature review aims to discuss several aspects of HPV-negative cervical cancers including the prevalence of HPV-negative cervical carcinomas and precancerous lesions and their relation to sample types (paraffin-embedded tissue blocks or liquid samples). Additionally, we explore possible reasons for false HPV-negative cases. Furthermore, we review histomorphological, molecular and clinical features of HPV-negative cervical cancers.Conclusions: The topic of HPV-negative cervical cancers is of importance given the drive towards HPV primary screening, initiation of self-collected HPV testing and widespread use of HPV vaccination.
format Article
id doaj-art-8d5acee15f3a45fca5be496c88693af1
institution OA Journals
issn 2097-0587
2667-1646
language English
publishDate 2025-02-01
publisher BMJ Publishing Group
record_format Article
series Gynecology and Obstetrics Clinical Medicine
spelling doaj-art-8d5acee15f3a45fca5be496c88693af12025-08-20T01:51:41ZengBMJ Publishing GroupGynecology and Obstetrics Clinical Medicine2097-05872667-16462025-02-015110.1136/gocm-2024-000160Human papillomavirus negative cervical cancers and precancerous lesions: prevalence, pathological and molecular features, and clinical implicationsLiron Pantanowitz0Chengquan Zhao1Xianxu Zeng2Wenli Dai31 Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA2 Department of Pathology, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA4 Department of Pathology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China1 Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USABackground: Cervical cancer is the fourth most common cancer in women globally. Although human papillomavirus (HPV) testing plays an increasing role in cervical cancer screening and treatment, HPV-negative cervical cancer remains a consistently reported entity globally. While numerous studies have focused on HPV-positive cervical cancers, detailed studies on HPV-negative counterparts remain limited.Results: This literature review aims to discuss several aspects of HPV-negative cervical cancers including the prevalence of HPV-negative cervical carcinomas and precancerous lesions and their relation to sample types (paraffin-embedded tissue blocks or liquid samples). Additionally, we explore possible reasons for false HPV-negative cases. Furthermore, we review histomorphological, molecular and clinical features of HPV-negative cervical cancers.Conclusions: The topic of HPV-negative cervical cancers is of importance given the drive towards HPV primary screening, initiation of self-collected HPV testing and widespread use of HPV vaccination.https://gocm.bmj.com/content/5/1/e000160.full
spellingShingle Liron Pantanowitz
Chengquan Zhao
Xianxu Zeng
Wenli Dai
Human papillomavirus negative cervical cancers and precancerous lesions: prevalence, pathological and molecular features, and clinical implications
Gynecology and Obstetrics Clinical Medicine
title Human papillomavirus negative cervical cancers and precancerous lesions: prevalence, pathological and molecular features, and clinical implications
title_full Human papillomavirus negative cervical cancers and precancerous lesions: prevalence, pathological and molecular features, and clinical implications
title_fullStr Human papillomavirus negative cervical cancers and precancerous lesions: prevalence, pathological and molecular features, and clinical implications
title_full_unstemmed Human papillomavirus negative cervical cancers and precancerous lesions: prevalence, pathological and molecular features, and clinical implications
title_short Human papillomavirus negative cervical cancers and precancerous lesions: prevalence, pathological and molecular features, and clinical implications
title_sort human papillomavirus negative cervical cancers and precancerous lesions prevalence pathological and molecular features and clinical implications
url https://gocm.bmj.com/content/5/1/e000160.full
work_keys_str_mv AT lironpantanowitz humanpapillomavirusnegativecervicalcancersandprecancerouslesionsprevalencepathologicalandmolecularfeaturesandclinicalimplications
AT chengquanzhao humanpapillomavirusnegativecervicalcancersandprecancerouslesionsprevalencepathologicalandmolecularfeaturesandclinicalimplications
AT xianxuzeng humanpapillomavirusnegativecervicalcancersandprecancerouslesionsprevalencepathologicalandmolecularfeaturesandclinicalimplications
AT wenlidai humanpapillomavirusnegativecervicalcancersandprecancerouslesionsprevalencepathologicalandmolecularfeaturesandclinicalimplications